Download PDF
Thromb Haemost 1983; 49(02): 144-146
DOI: 10.1055/s-0038-1657341
International Committee Communications
Schattauer GmbH Stuttgart

Report of the Working Party on Acquired Inhibitors of Coagulation: Studies of the “Lupus” Anticoagulant

D Green
*   The Atherosclerosis Program/Northwestern University, Rehabilitation Institute of Chicago, Illinois
,
C Hougie
**   The University of California, San Diego, LaJolla, California
,
F J Kazmier
***   The Mayo Clinic/Special Coagulation Lab, Rochester, Minnesota, U.S.A.
,
K Lechner
*+   The I. Medizinische Universitätsklinik, Vienna, Austria
,
P M Mannucci
+   The Universita Degli Studi Di Milano, Milan, Italy
,
C R Rizza
++   The Oxford Haemophilia Centre, Oxford, England
,
Y Sultan
+++   The Service d'Hematologie de I'Hdpital Cochin, Paris, France
› Author Affiliations
Further Information

Publication History

Received 11 January 1983

Accepted 04 February 1983

Publication Date:
18 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Keywords

Lupus anticoagulant - Inhibitors of coagulation
 

  • References

  • 1 Schleider MA, Nachman RL, Jaffe EA, Coleman M. A clinical study of the lupus anticoagulant. Blood 1976; 48: 499-509
    PubMedGoogle Scholar
  • 2 Denson KWE, Biggs R. Laboratory diagnosis, tests of clotting function and their standardization. Human Blood Coagulation, Hemostasis, and Thrombosis. Biggs R. (ed). p. 325. Blackwell Scientific Publications; Oxford: 1976
    Google Scholar
  • 3 Kaspar CK. et al. A more uniform measurement of factor VIII inhibitors. Thrombos Diathes Haemorrh 1975; 34: 869-872
    PubMedGoogle Scholar
  • 4 Kalish SB, Kurtides ES, Semerdjian RA, Vagher P. Bleeding in patients with activated partial thromboplastin time inhibitors. South Med J 1982; 75: 494-496
    CrossrefPubMedGoogle Scholar
  • 5 Shapiro SS, Thiagarajan P. Lupus anticoagulants. Prog Hemost Thromb 1982; 6: 263-286
    PubMedGoogle Scholar